Leonie, who writes Leoniefennell's Blog, is in search of answers as to why her son was given a dangerous antidepressant. What she sent me is a PDF of The British Journal of Psychiatry, July 1998, Vol 173.
It's yet another fine example of the psychopharmaceutical monopoly, how everyone [except patients] are connected to the pimping of antidepressant/antipsychotic medication.
Vol 173 is littered with advertising for antidepressant/antipsychotic medication, the taglines are really quite sickening considering what we all know about these drugs. The 1998 'pharmaceutical catalogue' throws up the following full page ads: [CLICK ON IMAGE TO ENLARGE]
CIPRAMIL [CELEXA IN US]
DOWNLOAD Media reports regarding Cipramil/Celexa
Antidepressant marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries due to the rare incidence of hepatotoxicity (liver damage), which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in every 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States and Canada. Several generic formulations of nefazodone are still available. [Source - Wikipedia]
EFEXOR [EFFEXOR IN US]
DOWNLOAD Media reports regarding Efexor/Effexor
Rivastigmine (sold under the trade name Exelon) is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions. [Source - Wikipedia]
HUNTERCOMBE MANOR [PSYCHIATRIC UNIT FOR ADOLESCENTS]
Now called Huntercombe Hospital
DOWNLOAD Media reports regarding Prozac
Johnson & Johnson lost a $257.7 million jury verdict in Louisiana for making misleading claims about the safety of the company’s Risperdal antipsychotic drug. J&J officials defrauded the state’s Medicaid system by wrongfully touting Risperdal as superior to competing antipsychotic drugs and minimizing its links to diabetes, said jurors in state court in Opelousas, Louisiana. [LINK]
Serdolect has a fivefold increased risk for sudden cardiac death and no proven advantage in suicide risk compared with risperidone. [LINK]
Pharmaceutical giant AstraZeneca will pay $520 million in fines to settle charges by the federal government that it illegally marketed the anti-psychotic drug Seroquel to children and elderly patients for uses not approved by the Food and Drug Administration. [MORE]
Side effects - Prolactin induction, thereby causing amenorrhoea and galactorrhoea in women, nausea, weight gain, insomnia, akathisia, sexual dysfunction, although much less than similar drugs in its class, and less commonly QT interval prolongation (which can lead to serious heart arrhythmias). Overdoses of amisulpride have been linked with torsades de pointes. [Wikipedia]
ZISPIN [AKA Remeron]
Clinical studies on Remeron and suicide showed that there is an increased risk of suicidal thoughts or behaviors in children and teenagers. [LINK]
Eli Lilly & Co. pleaded guilty to a charge that it illegally marketed the anti-psychotic drug Zyprexa for an unapproved use, and will pay $1.42 billion to settle civil suits and end the criminal investigation. [LINK]
On May 21, 2010, Ortho-McNeil plead guilty and was fined US$6.14 million by the FDA for promoting Topamax to treat psychiatric disorders, without applying for any approval and there was no data from any well-controlled clinical trial to demonstrate that Topamax was safe and effective to treat any psychiatric conditions. [Wikipedia]
DOWNLOAD Media reports regarding Seroxat/Paxil/Aropax.
Also read the now infamous Paxil 329 documents that GlaxoSmithKline [then Smith Kline Beecham] tried to hide - HERE
The British Journal of Psychiatry - serving the pharmaceutical industry and putting lives at risk.
Read The British Journal of Psychiatry, July 1998, Vol 173 HERE
Special thanks to Leonie Fennell for passing the information over to me.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING